Equitable Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Equitable Holdings’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Sell	2,860 -17	-0.6%	-$1.53K	﹤0.01%	1576
2026 Q1	$244K	Hold	2,877	–	–	﹤0.01%	1543
2025 Q4	$244K	Hold	2,877	–	–	﹤0.01%	1420
2025 Q3	$209K	Buy	+2,877	New	+$198K	﹤0.01%	1437
2025 Q2	–	Sell	-3,028	Closed	-$214K	–	1478
2025 Q1	$214K	Sell	3,028 -1,037	-26%	-$72.1K	﹤0.01%	1227
2024 Q4	$267K	Buy	4,065 +811	+25%	+$55.8K	﹤0.01%	1090
2024 Q3	$230K	Buy	+3,254	New	+$227K	﹤0.01%	1139

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Equitable Holdings's IHE Position: Q2 2026 in Review

Equitable Holdings reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.59% in Q2 2026, selling an estimated $1.53K and leaving 2,860 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

Equitable Holdings first reported a position in IHE in Q3 2024 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Equitable Holdings held 2,860 shares of iShares US Pharmaceuticals ETF worth $283K as of Q2 2026.
Equitable Holdings sold 17 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.53K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1576 holding.
Equitable Holdings first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and has held it in 7 quarters since.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.